Skip to main content
. 2010 May;49(3):335–343.

Table 1.

Summary of galantamine and donepezil pharmacokinetic data

Donepezil
Galantamine
Syringe Gavage Syringe Gavage
Maximal concentration (µM) 0.032 ± 0.004a 0.018 ± 0.020 0.196 ± 0.030 0.414 ± 0.160
Tmax (h; median [range])# 0.500 (0.5–0.5) 1.0 (0.5-2.0) 0.3 (0.1-0.3) 0.3 (0.3-0.5)
AUC(0-t) (µM • h) 0.104 ± 0.020 0.074 ± 0.005 0.282 ± 0.006 0.942 ± 0.405
AUCt/Dose (min • kg / L) 5.070 ± 0.540 3.900 ± 0.370 9.924 ± 0.141 31.283 ± 13.540

AUC, area under the time–concentration curve; t, time of the last measured blood sample

Data are expressed as mean ± SEM (n = 3).

a

Significantly (P < 0.05) different from value for gavage-dosed donepezil.